Clinical Trial Update: Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating TRU-016 plus bendamustine versus bendamustine alone in relapsed chronic lymphocytic leukemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• TRU-016

Snippet

Sponsor: Aptevo Therapeutics | Conditions: Chronic Lymphocytic Leukemia (CLL) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-01-06